Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inhibrx Biosciences (INBX) Shares Issued (2023 - 2025)

Inhibrx Biosciences (INBX) has disclosed Shares Issued for 3 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Shares Issued changed N/A to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, down 97.76% year-over-year, with the annual reading at $1.6 million for FY2025, 97.76% down from the prior year.
  • Shares Issued for Q4 2025 was $1.3 million at Inhibrx Biosciences, up from $352000.0 in the prior quarter.
  • The five-year high for Shares Issued was $38.7 million in Q1 2024, with the low at $21000.0 in Q3 2023.
  • Average Shares Issued over 3 years is $12.4 million, with a median of $1.2 million recorded in 2023.